Allurion Technologies (ALURD) Total Non-Current Liabilities (2022 - 2026)
Allurion Technologies (ALURD) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | - |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | 2.64 Bn |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | 3.53 Bn |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 9.58 Bn |
| 10 | Allurion Technologies | 60.75 Mn | 55.69 Mn | 1.23 Mn | 86.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.81 Mn |
| Dec 31, 2025 | 92.58 Mn |
| Sep 30, 2025 | 100.25 Mn |
| Jun 30, 2025 | 91.22 Mn |
| Mar 31, 2025 | 98.94 Mn |
| Dec 31, 2024 | 110.77 Mn |
| Sep 30, 2024 | 104.64 Mn |
| Jun 30, 2024 | 111.52 Mn |
| Mar 31, 2024 | 116.35 Mn |
| Dec 31, 2023 | 134.69 Mn |
| Sep 30, 2023 | 161.43 Mn |
| Jun 30, 2023 | 112.49 Mn |
| Dec 31, 2022 | 81.13 Mn |
| Sep 30, 2022 | -400,000.00 |